TMDX 91.21 (+3.98%)
US89377M1099Medical Devices & InstrumentsMedical Devices

TransMedics Group (TMDX) Stock Highlights

91.21 | +3.98%
2025-04-23 03:36:26
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.

Statistics

Range Today
88 92.01
Volume Today 1.16M
Range 1 Year
55 177.37
Volume 1 Year 335.29M
Range 3 Year
20.36 177.37
Volume 3 Year 616.25M
Range 10 Year
10 177.37
Volume 10 Year 812.25M

Highlights

Market Capitalization 2.98B (mid)
Floating Shares 32.46M
Current Price 91.21
Price To Earnings 79.74
Price To Revenue 7.14
Price To Book 12.98
Earnings Per Share 1.07
Payout Ratio 0%

Performance

Latest +3.98%
1 Month +29.76%
3 Months +60.58%
6 Months -26.67%
1 Year +8.57%
3 Years +319.16%
5 Years +458.88%
10 Years +350.42%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.